NCT00048048View on ClinicalTrials.gov

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

November 30, 2004

Conditions

Anemia

Interventions

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

Differing doses and frequencies of sc administration

Trial Locations (15)

14000

Mexico City

35211

Birmingham

48236

Detroit

64710

Monterrey

89106

Las Vegas

92103-8342

San Diego

48202-2689

Detroit

97201-2940

Portland

T6G 2B7

Edmonton

V6Z 1Y6

Vancouver

80-211

Gdansk

31-501

Krakow

50-417

Wroclaw

BT9 7LJ

Belfast

SE22 8PT

London

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00048048 - A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. | Biotech Hunter | Biotech Hunter